论文部分内容阅读
目的探讨蒙脱石散联合双歧杆菌乳杆菌三联活菌片治疗小儿腹泻的临床疗效。方法选取浚县妇幼保健院2014年11月—2015年10月收治的80例小儿腹泻患儿,采用随机数字表法分为观察组和对照组,各40例。两组患儿均给予常规治疗,在此基础上对照组给予蒙脱石散治疗,观察组在对照组的基础上给予双歧杆菌乳杆菌三联活菌片治疗,比较两组患者的临床疗效、症状改善时间(止泻时间、退热时间、腹痛消失时间和排便正常时间)及不良反应发生情况。结果观察组总有效率高于对照组,止泻时间、退热时间、腹痛消失时间和排便正常时间均短于对照组,差异有统计学意义(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论蒙脱石散联合双歧杆菌乳杆菌三联活菌片治疗小儿腹泻的临床疗效确切,可缩短症状改善时间,不良反应少。
Objective To investigate the clinical efficacy of montmorillonite powder combined with Lactobacillus bifidum triple active viable tablet in children with diarrhea. Methods 80 cases of infantile diarrhea admitted to Junxian Maternal and Child Health Hospital from November 2014 to October 2015 were randomly divided into observation group and control group with 40 cases in each group. The two groups of children were given routine treatment, on the basis of the control group given montmorillonite powder treatment, the observation group was given on the basis of the control group of Lactobacillus Bifidobacterium triple live viable tablets, the clinical efficacy of the two groups were compared, Symptom improvement time (diarrhea time, antipyretic time, abdominal pain disappear time and defecation normal time) and adverse reactions. Results The total effective rate of the observation group was higher than that of the control group. Diarrhea time, antipyretic time, abdominal pain disappearance time and defecation normal time were shorter than those in the control group. The difference was statistically significant (P <0.05). Two groups of patients with adverse reactions, the difference was not statistically significant (P> 0.05). Conclusions Montmorillonite powder combined with Bifidobacterium Lactobacillus triple active viable tablets for the treatment of children with diarrhea, clinical efficacy is exact, can shorten the time to improve symptoms, fewer adverse reactions.